OctoPlus appoints ceo
Jan Hendrik Egberts to replace Simon Sturge
‘The Board nominates Dr Egberts based on his successful track record in general management, investment management and business development, which he obtained at leading innovative and publicly listed companies,’ said Hans Stellingsma, chairman of OctoPlus.
‘We are sorry to see Simon go but we understand his decision to act on a unique job opportunity.’
Egberts will bring more than 20 years of experience in the pharmaceutical sector to OctoPlus. Most recently he was senior advisor in healthcare investments to private equity firm 3i Group.